IL93324A - Release means for administering pharmaceutical preparations orally - Google Patents

Release means for administering pharmaceutical preparations orally

Info

Publication number: IL93324A
Authority: IL; Israel
Prior art keywords: tube; therapeutic agent; grid; dose; outlet end
Prior art date: 1989-02-17

Application number

IL9332490A

Other languages

English (en)

Hebrew (he)

Other versions

IL93324A0 (en

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-17

Filing date

1990-02-08

Publication date

1994-02-27

1990-02-08 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1990-11-29 Publication of IL93324A0 publication Critical patent/IL93324A0/xx

1994-02-27 Publication of IL93324A publication Critical patent/IL93324A/en

Links

239000003814 drug Substances 0.000 title claims abstract description 140
229940124597 therapeutic agent Drugs 0.000 title claims abstract description 119
239000007788 liquid Substances 0.000 claims abstract description 42
210000000214 mouth Anatomy 0.000 claims abstract description 36
239000002245 particle Substances 0.000 claims abstract description 24
239000002552 dosage form Substances 0.000 claims description 25
239000012530 fluid Substances 0.000 claims description 20
229940079593 drug Drugs 0.000 claims description 18
239000010902 straw Substances 0.000 claims description 15
239000008188 pellet Substances 0.000 claims description 14
230000035622 drinking Effects 0.000 claims description 13
239000003795 chemical substances by application Substances 0.000 claims description 6
238000007789 sealing Methods 0.000 claims description 3
NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims 1
230000009471 action Effects 0.000 abstract description 10
230000000717 retained effect Effects 0.000 abstract description 5
238000000576 coating method Methods 0.000 description 21
239000011248 coating agent Substances 0.000 description 16
238000000034 method Methods 0.000 description 15
239000000203 mixture Substances 0.000 description 11
239000007787 solid Substances 0.000 description 11
239000013543 active substance Substances 0.000 description 10
238000009472 formulation Methods 0.000 description 10
235000019640 taste Nutrition 0.000 description 10
239000002775 capsule Substances 0.000 description 8
239000006186 oral dosage form Substances 0.000 description 8
239000000725 suspension Substances 0.000 description 8
238000010276 construction Methods 0.000 description 7
239000000463 material Substances 0.000 description 6
-1 polypropylene Polymers 0.000 description 6
239000000243 solution Substances 0.000 description 6
238000013268 sustained release Methods 0.000 description 6
239000012730 sustained-release form Substances 0.000 description 6
239000003826 tablet Substances 0.000 description 6
KEJCWVGMRLCZQQ-YJBYXUATSA-N Cefuroxime axetil Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(=O)OC(C)OC(C)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 KEJCWVGMRLCZQQ-YJBYXUATSA-N 0.000 description 5
229960002620 cefuroxime axetil Drugs 0.000 description 5
239000008187 granular material Substances 0.000 description 5
230000000873 masking effect Effects 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
239000011230 binding agent Substances 0.000 description 4
235000013305 food Nutrition 0.000 description 4
230000002496 gastric effect Effects 0.000 description 4
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
229920002472 Starch Polymers 0.000 description 3
230000001154 acute effect Effects 0.000 description 3
239000011324 bead Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
238000009826 distribution Methods 0.000 description 3
238000007908 dry granulation Methods 0.000 description 3
239000012669 liquid formulation Substances 0.000 description 3
230000036961 partial effect Effects 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000008569 process Effects 0.000 description 3
239000008107 starch Substances 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
238000005550 wet granulation Methods 0.000 description 3
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
239000004925 Acrylic resin Substances 0.000 description 2
229920000178 Acrylic resin Polymers 0.000 description 2
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
239000001856 Ethyl cellulose Substances 0.000 description 2
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
229920003148 Eudragit® E polymer Polymers 0.000 description 2
239000004698 Polyethylene Substances 0.000 description 2
239000004743 Polypropylene Substances 0.000 description 2
NEDGUIRITORSKL-UHFFFAOYSA-N butyl 2-methylprop-2-enoate;2-(dimethylamino)ethyl 2-methylprop-2-enoate;methyl 2-methylprop-2-enoate Chemical compound COC(=O)C(C)=C.CCCCOC(=O)C(C)=C.CN(C)CCOC(=O)C(C)=C NEDGUIRITORSKL-UHFFFAOYSA-N 0.000 description 2
MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
229920001249 ethyl cellulose Polymers 0.000 description 2
235000019325 ethyl cellulose Nutrition 0.000 description 2
239000003172 expectorant agent Substances 0.000 description 2
238000001125 extrusion Methods 0.000 description 2
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
230000006872 improvement Effects 0.000 description 2
CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
230000008447 perception Effects 0.000 description 2
229920000728 polyester Polymers 0.000 description 2
229920000573 polyethylene Polymers 0.000 description 2
229920001155 polypropylene Polymers 0.000 description 2
AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
235000021058 soft food Nutrition 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
229960000278 theophylline Drugs 0.000 description 2
YKFCISHFRZHKHY-NGQGLHOPSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;trihydrate Chemical compound O.O.O.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 YKFCISHFRZHKHY-NGQGLHOPSA-N 0.000 description 1
METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 description 1
RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 description 1
TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 1
SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
SGUAFYQXFOLMHL-UHFFFAOYSA-N 2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide Chemical compound C=1C=C(O)C(C(N)=O)=CC=1C(O)CNC(C)CCC1=CC=CC=C1 SGUAFYQXFOLMHL-UHFFFAOYSA-N 0.000 description 1
WZRJTRPJURQBRM-UHFFFAOYSA-N 4-amino-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 WZRJTRPJURQBRM-UHFFFAOYSA-N 0.000 description 1
241000220479 Acacia Species 0.000 description 1
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
208000019505 Deglutition disease Diseases 0.000 description 1
229920004943 Delrin® Polymers 0.000 description 1
108010061435 Enalapril Proteins 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
235000010643 Leucaena leucocephala Nutrition 0.000 description 1
208000019695 Migraine disease Diseases 0.000 description 1
PHVGLTMQBUFIQQ-UHFFFAOYSA-N Nortryptiline Chemical compound C1CC2=CC=CC=C2C(=CCCNC)C2=CC=CC=C21 PHVGLTMQBUFIQQ-UHFFFAOYSA-N 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
229930195708 Penicillin V Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
239000004809 Teflon Substances 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
229960001138 acetylsalicylic acid Drugs 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
229960004538 alprazolam Drugs 0.000 description 1
VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
229960000836 amitriptyline Drugs 0.000 description 1
KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
229960003022 amoxicillin Drugs 0.000 description 1
LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
230000003288 anthiarrhythmic effect Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
239000004004 anti-anginal agent Substances 0.000 description 1
230000001088 anti-asthma Effects 0.000 description 1
230000001430 anti-depressive effect Effects 0.000 description 1
230000003474 anti-emetic effect Effects 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
230000003561 anti-manic effect Effects 0.000 description 1
230000002921 anti-spasmodic effect Effects 0.000 description 1
229940124345 antianginal agent Drugs 0.000 description 1
239000000924 antiasthmatic agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
229940125681 anticonvulsant agent Drugs 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
239000000935 antidepressant agent Substances 0.000 description 1
229940005513 antidepressants Drugs 0.000 description 1
229940125683 antiemetic agent Drugs 0.000 description 1
239000002111 antiemetic agent Substances 0.000 description 1
229940125715 antihistaminic agent Drugs 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
229940030600 antihypertensive agent Drugs 0.000 description 1
239000002220 antihypertensive agent Substances 0.000 description 1
239000000228 antimanic agent Substances 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000002579 antinauseant Substances 0.000 description 1
229940125688 antiparkinson agent Drugs 0.000 description 1
239000000939 antiparkinson agent Substances 0.000 description 1
229940124575 antispasmodic agent Drugs 0.000 description 1
239000003434 antitussive agent Substances 0.000 description 1
229940124584 antitussives Drugs 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
229960002274 atenolol Drugs 0.000 description 1
239000002876 beta blocker Substances 0.000 description 1
229940097320 beta blocking agent Drugs 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
235000019658 bitter taste Nutrition 0.000 description 1
229960000725 brompheniramine Drugs 0.000 description 1
ZDIGNSYAACHWNL-UHFFFAOYSA-N brompheniramine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Br)C=C1 ZDIGNSYAACHWNL-UHFFFAOYSA-N 0.000 description 1
229940124630 bronchodilator Drugs 0.000 description 1
239000000168 bronchodilator agent Substances 0.000 description 1
FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
229960000830 captopril Drugs 0.000 description 1
QYIYFLOTGYLRGG-GPCCPHFNSA-N cefaclor Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 QYIYFLOTGYLRGG-GPCCPHFNSA-N 0.000 description 1
229960005361 cefaclor Drugs 0.000 description 1
229960004841 cefadroxil Drugs 0.000 description 1
NBFNMSULHIODTC-CYJZLJNKSA-N cefadroxil monohydrate Chemical compound O.C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=C(O)C=C1 NBFNMSULHIODTC-CYJZLJNKSA-N 0.000 description 1
229940081734 cellulose acetate phthalate Drugs 0.000 description 1
229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 description 1
229940106164 cephalexin Drugs 0.000 description 1
ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
230000001055 chewing effect Effects 0.000 description 1
229960003291 chlorphenamine Drugs 0.000 description 1
SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
229960001380 cimetidine Drugs 0.000 description 1
CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
229960004621 cinoxacin Drugs 0.000 description 1
VDUWPHTZYNWKRN-UHFFFAOYSA-N cinoxacin Chemical compound C1=C2N(CC)N=C(C(O)=O)C(=O)C2=CC2=C1OCO2 VDUWPHTZYNWKRN-UHFFFAOYSA-N 0.000 description 1
229960003405 ciprofloxacin Drugs 0.000 description 1
229960002896 clonidine Drugs 0.000 description 1
229940047766 co-trimoxazole Drugs 0.000 description 1
239000003086 colorant Substances 0.000 description 1
239000007891 compressed tablet Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
230000006378 damage Effects 0.000 description 1
239000000850 decongestant Substances 0.000 description 1
229940124581 decongestants Drugs 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
229960003529 diazepam Drugs 0.000 description 1
AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
229960004100 dirithromycin Drugs 0.000 description 1
WLOHNSSYAXHWNR-NXPDYKKBSA-N dirithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H]2O[C@H](COCCOC)N[C@H]([C@@H]2C)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 WLOHNSSYAXHWNR-NXPDYKKBSA-N 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
239000002934 diuretic Substances 0.000 description 1
229940030606 diuretics Drugs 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
229960000873 enalapril Drugs 0.000 description 1
238000009505 enteric coating Methods 0.000 description 1
239000002702 enteric coating Substances 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
230000003419 expectorant effect Effects 0.000 description 1
229940066493 expectorants Drugs 0.000 description 1
238000013265 extended release Methods 0.000 description 1
XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
229960001596 famotidine Drugs 0.000 description 1
229960002464 fluoxetine Drugs 0.000 description 1
210000001156 gastric mucosa Anatomy 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
239000011521 glass Substances 0.000 description 1
230000005484 gravity Effects 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
229960001680 ibuprofen Drugs 0.000 description 1
229960004801 imipramine Drugs 0.000 description 1
BCGWQEUPMDMJNV-UHFFFAOYSA-N imipramine Chemical compound C1CC2=CC=CC=C2N(CCCN(C)C)C2=CC=CC=C21 BCGWQEUPMDMJNV-UHFFFAOYSA-N 0.000 description 1
239000012729 immediate-release (IR) formulation Substances 0.000 description 1
229960000905 indomethacin Drugs 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
230000001788 irregular Effects 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
229960001977 loracarbef Drugs 0.000 description 1
JAPHQRWPEGVNBT-UTUOFQBUSA-M loracarbef anion Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CC[C@@H]32)C([O-])=O)=O)N)=CC=CC=C1 JAPHQRWPEGVNBT-UTUOFQBUSA-M 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
238000002483 medication Methods 0.000 description 1
229960002237 metoprolol Drugs 0.000 description 1
IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
206010027599 migraine Diseases 0.000 description 1
239000011707 mineral Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
239000002991 molded plastic Substances 0.000 description 1
230000000510 mucolytic effect Effects 0.000 description 1
229940066491 mucolytics Drugs 0.000 description 1
229940035363 muscle relaxants Drugs 0.000 description 1
239000003158 myorelaxant agent Substances 0.000 description 1
HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
229960001597 nifedipine Drugs 0.000 description 1
229960004872 nizatidine Drugs 0.000 description 1
SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
229960001180 norfloxacin Drugs 0.000 description 1
OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
229960001158 nortriptyline Drugs 0.000 description 1
235000020939 nutritional additive Nutrition 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
229960004535 oxazepam Drugs 0.000 description 1
ADIMAYPTOBDMTL-UHFFFAOYSA-N oxazepam Chemical compound C12=CC(Cl)=CC=C2NC(=O)C(O)N=C1C1=CC=CC=C1 ADIMAYPTOBDMTL-UHFFFAOYSA-N 0.000 description 1
LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
229960005489 paracetamol Drugs 0.000 description 1
229960002035 penbutolol Drugs 0.000 description 1
KQXKVJAGOJTNJS-HNNXBMFYSA-N penbutolol Chemical compound CC(C)(C)NC[C@H](O)COC1=CC=CC=C1C1CCCC1 KQXKVJAGOJTNJS-HNNXBMFYSA-N 0.000 description 1
229940056367 penicillin v Drugs 0.000 description 1
239000008014 pharmaceutical binder Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 description 1
229960002508 pindolol Drugs 0.000 description 1
PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229940100467 polyvinyl acetate phthalate Drugs 0.000 description 1
239000000843 powder Substances 0.000 description 1
IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 1
229960001289 prazosin Drugs 0.000 description 1
230000002028 premature Effects 0.000 description 1
229960003712 propranolol Drugs 0.000 description 1
239000011253 protective coating Substances 0.000 description 1
229940001470 psychoactive drug Drugs 0.000 description 1
239000004089 psychotropic agent Substances 0.000 description 1
230000000506 psychotropic effect Effects 0.000 description 1
229960000620 ranitidine Drugs 0.000 description 1
VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
230000011514 reflex Effects 0.000 description 1
238000012827 research and development Methods 0.000 description 1
229960002052 salbutamol Drugs 0.000 description 1
230000001953 sensory effect Effects 0.000 description 1
230000021317 sensory perception Effects 0.000 description 1
229940126589 solid medicine Drugs 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
239000000021 stimulant Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
238000009495 sugar coating Methods 0.000 description 1
230000009747 swallowing Effects 0.000 description 1
239000006068 taste-masking agent Substances 0.000 description 1
238000011287 therapeutic dose Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
229960004605 timolol Drugs 0.000 description 1
239000003204 tranquilizing agent Substances 0.000 description 1
230000002936 tranquilizing effect Effects 0.000 description 1
238000011282 treatment Methods 0.000 description 1
JOFWLTCLBGQGBO-UHFFFAOYSA-N triazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1Cl JOFWLTCLBGQGBO-UHFFFAOYSA-N 0.000 description 1
229960003386 triazolam Drugs 0.000 description 1
229940124549 vasodilator Drugs 0.000 description 1
239000003071 vasodilator agent Substances 0.000 description 1
229960001722 verapamil Drugs 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0038—Straws
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47G—HOUSEHOLD OR TABLE EQUIPMENT
- A47G21/00—Table-ware
- A47G21/18—Drinking straws or the like
- A47G21/183—Drinking straws or the like with means for changing the flavour of the liquid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

IL9332490A 1989-02-17 1990-02-08 Release means for administering pharmaceutical preparations orally IL93324A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US31263689A	1989-02-17	1989-02-17

Publications (2)

Publication Number	Publication Date
IL93324A0 IL93324A0 (en)	1990-11-29
IL93324A true IL93324A (en)	1994-02-27

Family

ID=23212351

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL9332490A IL93324A (en)	1989-02-17	1990-02-08	Release means for administering pharmaceutical preparations orally

Country Status (15)

Country	Link
US (1)	US4981468A (da)
EP (1)	EP0383503B1 (da)
JP (1)	JPH02274252A (da)
KR (1)	KR900012591A (da)
AT (1)	ATE91878T1 (da)
AU (1)	AU625179B2 (da)
CA (1)	CA2009858A1 (da)
DE (1)	DE69002345T2 (da)
DK (1)	DK0383503T3 (da)
ES (1)	ES2043268T3 (da)
HU (1)	HUT57573A (da)
IE (1)	IE63590B1 (da)
IL (1)	IL93324A (da)
NZ (1)	NZ232482A (da)
ZA (1)	ZA90945B (da)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5900250A (en) *	1992-05-13	1999-05-04	Alza Corporation	Monoglyceride/lactate ester permeation enhancer for oxybutnin
US5318520A (en) *	1992-10-16	1994-06-07	Nakao Naomi L	Safety method and device for intravenous feed systems
CA2165802A1 (en) *	1993-09-29	1995-04-06	Eun Soo Lee	Monoglyceride/lactate ester permeation enhancer for oxybutynin
CA2226267C (en) *	1995-07-21	2008-01-22	Alza Corporation	Device and method for oral delivery of an active agent formulation in the form of discrete units
AU742022B2 (en) *	1995-07-21	2001-12-13	Alza Corporation	Oral delivery of discrete units
US5780058A (en)	1995-07-21	1998-07-14	Alza Corporation	Oral delivery of discrete units
US5707353A (en) *	1995-12-21	1998-01-13	Abbott Laboratories	Oral administration of beneficial agents
US20030087005A1 (en) *	1996-10-10	2003-05-08	Peter Baron	Drink flavouring straw
AUPS270602A0 (en) *	2002-05-31	2002-06-20	Baron, Peter	Drink flavouring straw
EP0942656B1 (en) *	1996-10-10	2003-05-21	Peter Baron	Apparatus for producing a flavoured beverage
AU729905B2 (en) *	1996-10-18	2001-02-15	Alza Corporation	Multiple flow path device for oral delivery of discrete units
EP0936894B1 (en) *	1996-10-18	2001-09-12	ALZA Corporation	Active agent delivery device
US6024721A (en) *	1996-10-18	2000-02-15	Alza Corporation	Mixing system for an active agent delivery device
WO1998034598A2 (en) *	1997-02-07	1998-08-13	Gist-Brocades B.V.	Homogeneous granulated formulations for dose sipping technology
ES2182303T3 (es)	1997-05-16	2003-03-01	Alza Corp	Configuraciones reguladoras del flujo para un dispositivo de administracion de agents activos.
US5945123A (en) *	1998-04-02	1999-08-31	K-V Pharmaceutical Company	Maximizing effectiveness of substances used to improve health and well being
US20040062802A1 (en) *	1998-04-02	2004-04-01	Hermelin Victor M.	Maximizing effectiveness of substances used to improve health and well being
JP2002528483A (ja) *	1998-10-30	2002-09-03	マクニール−ピーピーシー・インコーポレイテッド	顆粒状で自由流動性の薬剤組成物、およびその経口投与のためのストロー状の投与形態
US6217545B1 (en)	1999-02-08	2001-04-17	Porex Technologies Corp.	Filter with varying density which is responsive to fluid flow
US6544555B2 (en) *	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US7089934B2 (en) *	2000-02-28	2006-08-15	Vectura Limited	Delivery of oral drugs
US20020068078A1 (en) *	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
DE10228173A1 (de) *	2002-03-27	2003-10-09	Gruenenthal Gmbh	System zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen
US20050118245A1 (en) *	2002-03-27	2005-06-02	Wilsmann Klaus M.	Assembled unit consisting of individually separable, transdermal, therapeutic systems
DE10228175A1 (de) *	2002-03-27	2003-10-09	Gruenenthal Gmbh	Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen
DE10228179A1 (de) *	2002-06-24	2004-01-22	Grünenthal GmbH	Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen
DE10228176A1 (de) *	2002-06-24	2004-01-22	Grünenthal GmbH	Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen
DE10228171A1 (de) *	2002-06-24	2004-01-22	Grünenthal GmbH	Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen
DE10228192A1 (de) *	2002-06-24	2004-01-15	Grünenthal GmbH	Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen
US7524515B2 (en) *	2003-01-10	2009-04-28	Mutual Pharmaceuticals, Inc.	Pharmaceutical safety dosage forms
DE10308175A1 (de) *	2003-02-25	2004-09-02	Grünenthal GmbH	Darreichungsform und Kit zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen
US6966252B2 (en) *	2003-03-31	2005-11-22	Mcneil-Ppc, Inc.	Hydrophilic substance dispensing device
CN1787797A (zh) *	2003-05-14	2006-06-14	株式会社吴羽	口服用固态成形物的吞咽用收纳体,该收纳体用容器及吞咽方法
US20040253351A1 (en) *	2003-06-11	2004-12-16	Killips Lynn Ramblas	Apparatus and method for mixing confectionary with fluids
DE10342514A1 (de) *	2003-09-12	2005-04-07	Grünenthal GmbH	Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen, Kit und Verwendung
DE10342513A1 (de) *	2003-09-12	2005-05-12	Gruenenthal Gmbh	Darreichungsform zur oralen Verabreichung von Wirkstoffen, Vitaminen und/oder Nährstoffen, Kit und Verwendung
US20050103879A1 (en) *	2003-11-19	2005-05-19	Robinson Ted R.	Straw
US20050116057A1 (en) *	2003-12-01	2005-06-02	Hamer Douglas T.	Novelty beverages straw
US7431175B2 (en) *	2004-07-16	2008-10-07	Roger Heilos	Drinking cup lid for assisting in ingestion of medication
US20070051741A1 (en) *	2005-09-02	2007-03-08	Kraft Foods Holdings, Inc.	Methods for the application of ingredients to the inside of a straw
NL1031129C2 (nl) *	2005-12-01	2007-06-04	Asepticstraw Internat B V	Artikel voor het bewegen van een medium voor te eten en/of drinken.
AR060029A1 (es) *	2006-03-02	2008-05-21	Unistraw Patent Holdings Ltd	Pajilla para beber adaptada para acondicionar progresivamente un ingrediente activo y metodo de fabricar dicha pajilla
US20080075809A1 (en) *	2006-09-21	2008-03-27	Anderson Michael R	Drinking straw for dispensing substances with one-way valve
KR101445891B1 (ko) *	2007-01-05	2014-10-02	아셀알엑스 파마슈티컬스 인코퍼레이티드	경구 경점막 제형의 투여를 위한 저장 및 분배 장치
WO2008094877A2 (en) *	2007-01-30	2008-08-07	Drugtech Corporation	Compositions for oral delivery of pharmaceuticals
US20080197141A1 (en) *	2007-02-20	2008-08-21	Felfoldi Edesseggyarto Kft.	Drinking Straw
US8679541B2 (en) *	2007-03-14	2014-03-25	Particle Dynamics International, Llc	Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals
MX2009010891A (es) *	2007-04-10	2010-02-17	Sandoz Ag	Dispositivo para la aplicacion oral de una sustancia.
FR2920308B1 (fr) *	2007-09-05	2011-02-25	Unither Dev	Forme pharmaceutique pour l'administration par voie orale de principes actifs.
US7997509B2 (en) *	2008-04-08	2011-08-16	Dana Karklins	Portion-controlled dispensing straw assembly
US9629810B2 (en) *	2008-09-10	2017-04-25	Sandoz Ag	Capsule with soluble blocking element
GB2480827B (en) *	2010-06-01	2012-06-06	Kraft Foods R & D Inc	Improvements in the preparation of beverages and liquid food products
SMT202100546T1 (it)	2011-09-19	2021-11-12	Orexo Ab	Compresse per via sublinguale resistenti all'abuso comprendenti buprenorfina e naloxone
US9017749B2 (en)	2011-12-21	2015-04-28	Babatope Sewande Ayeni	Flavored straw with a flavor delivery system
US9751056B2 (en)	2012-01-23	2017-09-05	Merit Medical Systems, Inc.	Mixing syringe
US8834449B2 (en) *	2012-01-23	2014-09-16	Ikomed Technologies, Inc.	Mixing syringe
WO2014006620A1 (en)	2012-07-05	2014-01-09	P.C.O.A. Devices Ltd.	Medication dispenser
CN104619604B (zh) *	2012-07-30	2017-04-05	P.C.O.A.设备有限公司	用于容纳和分配固体药用药丸的容器
US20140343487A1 (en) *	2013-05-14	2014-11-20	Semion Hlebnikov	Drinking straw that contains substances for treating the side effects of alcohol consumption
CA2902911C (en)	2014-10-31	2017-06-27	Purdue Pharma	Methods and compositions particularly for treatment of attention deficit disorder
WO2016193242A1 (en) *	2015-06-01	2016-12-08	Unistraw Holdings Pte. Ltd.	Formulations of cns-stimulants and vitamins
AU2016274646A1 (en)	2015-06-10	2017-12-07	Unistraw Holdings Pte. Ltd.	Drinking straw with internal coating
ES2842124T3 (es) *	2015-12-22	2021-07-12	Alterno Labs D O O	Pajita de beber precargada con un cierre de válvula de ranura transversal en ambos extremos
PL3506872T3 (pl)	2017-06-20	2020-06-01	Sisteks D.O.O.	Wcześniej napełniona słomka do picia ze szczelinowym zaworowym zamknięciem na obu końcach
WO2020021111A1 (en) *	2018-07-27	2020-01-30	Sisteks D.O.O.	Straw for oral administration of pharmaceutical formulation
US10722473B2 (en)	2018-11-19	2020-07-28	Purdue Pharma L.P.	Methods and compositions particularly for treatment of attention deficit disorder
CN111407663B (zh)	2019-01-07	2026-01-02	上海汉都医药科技有限公司	一种口服给药递送装置
WO2021062987A1 (zh)	2019-09-30	2021-04-08	上海汉都医药科技有限公司	固体口服制剂的药物容置装置及含其的口服给药递送装置
US12559289B2 (en)	2020-05-18	2026-02-24	air up group GmbH	Aroma container
US11272799B2 (en)	2020-05-29	2022-03-15	Unistraw Corp.	Drinking straw with internal coating
EP3944792A1 (de) *	2020-07-30	2022-02-02	air up group GmbH	Trinkvorrichtung und trinkgefäss
US20230414454A1 (en) *	2022-06-23	2023-12-28	Michael William Babb	Medication or vitamin swallowing aid
US20250302218A1 (en) *	2024-03-30	2025-10-02	Red River Tea Company	Container straw, beverage kit, method for preparing the beverage kit, and method of using the beverage kit
WO2025221761A2 (en) *	2024-04-17	2025-10-23	Genzyme Corporation	Medicament container and kit for reconstituting a lyophilized medicament

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US121684A (en) *		1871-12-05		Improvement in devices for administering pills
US580527A (en) *		1897-04-13		Drinking-tube
US430928A (en) *		1890-06-24		Device for administering medicine to animals
US697209A (en) *	1901-07-24	1902-04-08	Benno Koppenhagen	Device for facilitating taking pills.
US1236029A (en) *	1916-08-10	1917-08-07	George H Williams	Drinking device.
US1685280A (en) *	1927-07-16	1928-09-25	Lester L Findley	Powder-placing syringe
US2436505A (en) *	1945-08-24	1948-02-24	Rall John H Du	Pill douser
US2753267A (en) *	1954-02-08	1956-07-03	Jere Bayard	Flavored drinking straw machine and method
US2846313A (en) *	1956-04-23	1958-08-05	Jere Bayard	Flavored drinking straw
US3517884A (en) *	1968-08-05	1970-06-30	Stephen D Horvath	Spiral drinking straw
US3615595A (en) *	1969-04-08	1971-10-26	Nat Patent Dev Corp	Flavored drinking straw
US3905477A (en) *	1972-03-14	1975-09-16	Union Carbide Corp	Tamperproof pouch label
US3980074A (en) *	1973-07-18	1976-09-14	Beecham Group Limited	Device for the administration of powders
US4581013A (en) *	1982-04-19	1986-04-08	Jane C. A. Hayes	Doser for orally administering medicine
US4440207A (en) *	1982-05-14	1984-04-03	Baxter Travenol Laboratories, Inc.	Antibacterial protective cap for connectors
DE3245711A1 (de) *	1982-12-10	1984-06-14	Deutsche Granini Gmbh & Co Kg, 4800 Bielefeld	Trinkvorrichtung fuer erfrischungsgetraenke
US4792333A (en) *	1986-11-04	1988-12-20	Strawdose, Inc.	Unit dose drug package and administering device

1990
- 1990-01-12 US US07/464,481 patent/US4981468A/en not_active Expired - Fee Related
- 1990-02-08 IL IL9332490A patent/IL93324A/en not_active IP Right Cessation
- 1990-02-08 ZA ZA90945A patent/ZA90945B/xx unknown
- 1990-02-09 ES ES90301427T patent/ES2043268T3/es not_active Expired - Lifetime
- 1990-02-09 EP EP90301427A patent/EP0383503B1/en not_active Expired - Lifetime
- 1990-02-09 DK DK90301427.2T patent/DK0383503T3/da active
- 1990-02-09 DE DE90301427T patent/DE69002345T2/de not_active Expired - Fee Related
- 1990-02-09 AT AT90301427T patent/ATE91878T1/de active
- 1990-02-12 NZ NZ232482A patent/NZ232482A/en unknown
- 1990-02-12 CA CA002009858A patent/CA2009858A1/en not_active Abandoned
- 1990-02-13 KR KR1019900001734A patent/KR900012591A/ko not_active Ceased
- 1990-02-14 AU AU49822/90A patent/AU625179B2/en not_active Ceased
- 1990-02-15 IE IE55990A patent/IE63590B1/en not_active IP Right Cessation
- 1990-02-15 JP JP2035080A patent/JPH02274252A/ja active Pending
- 1990-02-16 HU HU90842A patent/HUT57573A/hu unknown

Also Published As

Publication number	Publication date
ES2043268T3 (es)	1993-12-16
NZ232482A (en)	1992-12-23
DE69002345D1 (de)	1993-09-02
IE900559L (en)	1990-08-17
DK0383503T3 (da)	1993-09-20
KR900012591A (ko)	1990-09-01
HUT57573A (en)	1991-12-30
ATE91878T1 (de)	1993-08-15
DE69002345T2 (de)	1993-12-09
HU900842D0 (en)	1990-04-28
IE63590B1 (en)	1995-05-17
US4981468A (en)	1991-01-01
CA2009858A1 (en)	1990-08-17
AU625179B2 (en)	1992-07-02
IL93324A0 (en)	1990-11-29
AU4982290A (en)	1990-08-23
EP0383503A1 (en)	1990-08-22
JPH02274252A (ja)	1990-11-08
EP0383503B1 (en)	1993-07-28
ZA90945B (en)	1991-10-30

Legal Events

Date	Code	Title
1996-05-14	KB	Patent renewed
2000-08-13	KB	Patent renewed
2004-11-10	RH1	Patent not in force

Publication	Publication Date	Title
US4981468A (en)	1991-01-01	Delivery device for orally administered therapeutic agents
JP3285366B2 (ja)	2002-05-27	活性薬剤放出デバイス用の流動制御手段構造
KR100449538B1 (ko)	2004-12-17	개별유니트의경구투여
WO2012052853A2 (en)	2012-04-26	Oral dosing device for administration of medication
US20110224648A1 (en)	2011-09-15	Syringe Filter Cap and Method of Using the Same for Administration of Medication Dosage
EP3628016B1 (en)	2025-01-01	System for dosing and dispensing medication
JP3287576B2 (ja)	2002-06-04	別々の単一体の経口投与用複数流路装置
JP2000509312A (ja)	2000-07-25	活性物質送出装置のクロージャ・システム
EP1629820A1 (en)	2006-03-01	Housing body for deglutition of solid molding for oral ingestion, container for the housing body, and deglutition method
AU2002334476A1 (en)	2003-06-05	Intraruminal device
WO2003024355A1 (en)	2003-03-27	Intraruminal device
US20060043207A1 (en)	2006-03-02	Apparatus, kit and related methods for administering substances
ES2659814T3 (es)	2018-03-19	Dispositivo para la administración por vía oral de principios activos
US20060147497A1 (en)	2006-07-06	Administration form and kit for the oral administration of active substances, vitamins and/or nutrients and use thereof
HK1015671B (en)	2003-12-12	Oral delivery of discrete units
MXPA98000596A (en)	1999-04-06	Oral asset system of discrete agent act units